###begin article-title 0
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
The Zinc Finger SET Domain Gene Prdm14 Is Overexpressed in Lymphoblastic Lymphomas with Retroviral Insertions at Evi32
###end article-title 0
###begin p 1
Conceived and designed the experiments: EJD MJJ. Performed the experiments: EJD. Analyzed the data: EJD MJJ. Wrote the paper: EJD MJJ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 261 286 <span type="species:ncbi:11791">AKV murine leukemia virus</span>
AKXD recombinant inbred strains of mice have proven to be very useful in the identification of potential oncogenes and tumor suppressors involved in the development of lymphoid and myeloid malignancies. In these tumors, the hematopoietic insertion of an active AKV murine leukemia virus (MuLV) is associated with the onset of disease. Common sites of retroviral insertion (CIS) identify genes causally associated with the development or initiation of lymphoma.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32),</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
In the present study, we analyzed a previously uncharacterized CIS, Ecotropic Viral Integration Site 32 (Evi32), which is located on mouse chromosome 1. We analyzed candidate genes in the region to identify those involved in Evi32 mediated oncogenesis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
Here we show that proviral insertion at Evi32 correlates with significant overexpression of a putative transcription factor, PR-domain containing 14 (Prdm14). Tumors with insertions at Evi32 are consistently lymphoid in nature. Prdm14 is normally expressed early in embryonic development with the highest expression in undifferentiated embryonic stem (ES) cells. This study implicates Prdm14 as a proto-oncogene involved in lymphoblastic lymphoma formation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 428 431 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Sorensen1">[1]</xref>
###xml 799 802 799 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Uren1">[2]</xref>
###xml 1001 1004 1001 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 1112 1115 1112 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Gilbert1">[4]</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 851 856 <span type="species:ncbi:10090">mouse</span>
Retroviral mutagenesis is an invaluable tool for the identification of novel genes involved in the development and progression of cancer in mice. Germ line retroviruses in certain inbred mouse strains replicate and infect other cells within the hematopoietic system. Integrated proviruses may alter the expression of nearby genes, because the long terminal repeat (LTR) elements contain enhancers and promoters of transcription [1]. If a proviral integration alters gene expression in such a way that it gives a growth advantage to host cells, a clonal expansion of those cells can occur, ultimately leading to tumor formation. Somatic proviral insertions contained in tumor tissue act as a molecular tag for the identification of genomic loci containing genes with oncogenic transformation ability [2]. In this study, several AKXD recombinant inbred mouse strains were examined that harbor endogenous replication competent proviruses in their germline and have a high incidence of lymphoma formation [3]. Each AKXD strain has variable susceptibility to lymphoma formation affecting both cell type and frequency [4].
###end p 9
###begin p 10
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki1">[5]</xref>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki2">[6]</xref>
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Yamashita1">[7]</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 447 458 447 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NCoA2/Tif2)</italic>
###xml 458 461 458 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki1">[5]</xref>
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki2">[6]</xref>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Yamashita1">[7]</xref>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 907 910 907 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Jenuwein1">[8]</xref>
###xml 1118 1124 1118 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Blimp1</italic>
###xml 1192 1195 1192 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Schneider1">[9]</xref>
###xml 1224 1230 1224 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1298 1302 <span type="species:ncbi:10090">mice</span>
Since it is highly unlikely that a proviral integration would occur in the same region multiple times in the absence of oncogenic selection, CISs are assembled to eliminate non-pathogenic insertions. One CIS that was identified in multiple retroviral insertional mutagenesis cancer screens is Evi32[3], [5], [6], [7]. In previous work, Evi32 was believed to affect flanking gene nuclear receptor coactivator 2/transcription intermediary factor 2 (NCoA2/Tif2)[5], [6], [7]. Here we show that a putative transcription factor, Prdm14, is overexpressed in tumors with proviral integration at Evi32. Prdm14 is normally expressed at low levels in most control tissues tested but is massively upregulated in all Evi32 tumors. Prdm14 contains a SET domain and six zinc finger repeats. SET domains are contained in a variety of transcription factors and have been shown to be responsible for methylation of histones [8]. Interestingly, a large proportion of genes containing SET domains have been implicated in leukemia/lymphoma, such as the mixed-lineage leukemia (Mll) proteins and B Lymphocyte-induced Maturation Protein 1 (Blimp1) suggesting that this domain is commonly involved in tumorigenesis [9]. Our research suggests that Prdm14 is a novel proto-oncogene involved in the formation of lymphoma in mice.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Evi32
###end title 12
###begin p 13
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 211 220 211 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1a</xref>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 490 498 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1)</italic>
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 817 826 817 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1c</xref>
###xml 901 906 901 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 948 951 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1016 1021 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
VISA PCR identified two tumors from mice 27-001 and 27-142 (27 indicates AKXD strain 27 followed by the mouse number) with insertions at Evi32[3]. Evi32 is located between Tif2 and Prdm14 on mouse chromosome 1 (Figure 1a). Both insertion sites are located very close to the start site of Prdm14, 27-001 is 151bp from the first exon, and 27-142 is 753 bp. Both insertions are located approximately 15 kb from Tif2, and 136 kb from solute carrier organic anion transporter family member 5A1 (Slco5a1). The provirus in 27-001 inserted in the same orientation as Prdm14, and 27-142 inserted in the opposite direction. Southern blot analysis after KpnI digestion showed that unique tumor specific bands were present in both Evi32 tumors, indicating the presence of somatically acquired proviral integrations at the locus (Figure 1c). The intensity of the rearranged band indicates that the integrations at Evi32 are monoclonal. Digestion with EcoRV and XbaI also confirmed somatically acquired proviral rearrangements at Evi32 (data not shown).
###end p 13
###begin title 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Evi32 Viral Insertion Sites.
###end title 14
###begin p 15
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 560 566 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 827 833 827 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1000 1006 1000 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1132 1135 1132 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1219 1224 1219 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1286 1291 1286 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1361 1366 1361 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
1a) The genomic locus surrounding Evi32 insertions. Locations of proviral insertions were determined by either VISA PCR or by PCR after identification of Evi32 integrations. Arrows indicate direction of transcription and the orientation of the retroviral integration. The exact orientation and location of the retroviral integration in animal 18-077 was not determined, but it is contained between the HindIII and XbaI digestion sites as determined by Southern blot analysis. Table at top right indicates the distance of each retrovirus from the first exon of Prdm14. 1b) Closeup view of Evi32 integrations. Restriction enzymes indicated were those used in digestion of tumor DNA to show genomic rearrangements at Evi32. Arrow indicates direction of transcription of Prdm14, and the black boxes show the eight exons of Prdm14. Prdm14 gene structure is based on VEGA prediction (OTTMUSG00000017097) obtained from the Ensembl database. RT-PCR amplification indicates that the VEGA prediction is a true Prdm14 transcript. 1c) Southern blots showing retroviral integrations at Evi32. Genomic DNA from indicated tumors was digested with KpnI. Brain serves as somatic tissue control from same animal to show rearrangement of Evi32 locus within the tumor tissue only. Rearranged bands seen in Evi32 tumors are indicated by asterisks and show genomic rearrangements at Evi32. BR = Brain, SP = Spleen, LN = Lymph Node.
###end p 15
###begin p 16
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 128 131 128 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1c</xref>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 597 603 597 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 605 614 605 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1b</xref>
###xml 899 903 899 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 911 914 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 947 953 947 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 967 976 967 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1b</xref>
###xml 1170 1173 1170 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1434 1456 1434 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003823.s001">upplementary Figure S1</xref>
###xml 1461 1469 1461 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003823.s003">Table S1</xref>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 777 782 <span type="species:ncbi:10090">mouse</span>
To identify additional Evi32 tumors, all of our AKXD tumors (from 204 animals) were further screened by Southern blotting using EcoRV digestion. This analysis revealed that tumors from mice 27-186 and 18-077 (from AKXD strain 18, mouse 77) contain rearrangements at Evi32 (Figure 1c). Digestion of 18-077 and 27-186 genomic DNA with EcoRI indicates that both of these proviruses are ecotropic (data not shown). The retroviral insertion in tumor 27-186 is located approximately 450 bp from the first exon of Prdm14 between the 27-001 and 27-142 insertions and integrated in the same orientation as Prdm14 (Figure 1b). The genomic location of this insertion was determined using PCR amplification (data not shown). The exact location of the insertion in the tumors obtained from mouse 18-077 was not determined, but it is located within the 1.4 kb region (as determined by Southern blot analysis with HindIII and XbaI) surrounding the first exon of Prdm14 indicated in Figure 1b. We were unable to amplify the virus using viral specific primers, which could be due to retroviral rearrangements that prevented PCR amplification from the virus. Southern blot analysis after KpnI digestion indicates that the LTR elements may have been deleted in 18-077, making precise localization difficult. Analysis of the number of monoclonal ecotropic somatic retroviral integrations in the tumors indicated a relatively low number of integrations (Supplementary Figure S1 and Table S1). Southern analysis of tumors obtained from 27-186 and 18-077 indicated just a single retroviral integration event. Tumors from 27-001 and 27-142 had three and two somatic insertions respectively.
###end p 16
###begin title 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Tif2 and Slco5a1 are not misexpressed in tumors containing insertions at Evi32
###end title 17
###begin p 18
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Lazo1">[10]</xref>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g002">Figure 2a</xref>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 535 542 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Quantitative RT-PCR (Q RT-PCR) was used to determine the level of expression of the genes surrounding Evi32. Since retroviruses can alter expression of genes up to 200 kb away [10], we analyzed expression of Slco5a1 in tumors with Evi32 proviral integrations (Figure 2a). We found that Slco5a1 was expressed in all Evi32 tumors at lower levels than seen in normal spleen, thymus, and bone marrow. Lower levels of expression of Slco5a1 were also observed in all tumors that lacked proviral insertions at Evi32. Therefore, expression of Slco5a1 is not significantly altered by proviral integration at Evi32.
###end p 18
###begin title 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Tif2 and Slco5a1 are not misexpressed in Evi32 tumors.
###end title 19
###begin p 20
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 290 297 290 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 852 856 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 901 906 901 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 1125 1130 1125 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1171 1175 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
2a) Q RT-PCR was performed on cDNA prepared from total RNA samples from tumors with and without insertions at Evi32 and control tissue obtained from 8 week old C57BL/6J mice. Expression of Slco5a1 was normalized to 18S expression levels and then quantified. We found that the expression of Slco5a1 does not appear to be consistently altered with Evi32 proviral insertions and is expressed at lower levels than seen in normal spleen, thymus, and bone marrow. Expression levels are shown on a log scale to show lower levels of expression. 2b) Expression of Tif2 was quantified in the same manner as Slco5a1. This analysis revealed that Tif2 is expressed at similar or lower levels than normal spleen, thymus, or bone marrow in all Evi32 tumors. Expression levels are shown on a log scale to show lower levels of expression. 2c) Northern blot analysis of Tif2 was performed using total RNA obtained from Evi32 tumor 27-186 and control tissue obtained from 8 week old C57BL/6J mice. The probe to Tif2 was directed towards common exons found in all isoforms. Sizes were estimated using 18S and 26S migration distances. The 27-186 Evi32 tumor showed the greatest expression of Tif2 as determined by Q RT-PCR, but shows no increase in expression by northern analysis. SP = Spleen, LN = Lymph Node, Th = Thymus.
###end p 20
###begin p 21
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 69 78 69 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g002">Figure 2b</xref>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 492 501 492 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g002">Figure 2c</xref>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Q RT-PCR was also used to determine the level of expression of Tif2 (Figure 2b), which is listed in the Retrovirus Tagged Cancer Gene Database (RTCGD) as the affected putative oncogene associated with viral insertion in this region (). All Evi32 tumors expressed Tif2 at similar or lower levels than normal hematopoietic tissues (spleen, thymus, and bone marrow). Additionally, the level of Tif2 expression by northern blot analysis in tumor 27-186 appeared to be the same as control spleen (Figure 2c). Therefore, no consistent alteration in the expression of Tif2 could be correlated with proviral insertion at Evi32.
###end p 21
###begin p 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF2</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOZ)</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF2</italic>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Deguchi1">[11]</xref>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2,</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g002">Figure 2c</xref>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Hong1">[12]</xref>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Chen1">[13]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Anzick1">[14]</xref>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
TIF2 is capable of inducing acute myeloid leukemia as a gene fusion product with monocytic leukemia zinc finger (MOZ). However, expression of unaltered TIF2 alone is unable to induce leukemia formation [11]. To rule out any rearrangements that may result in aberrant transcripts of Tif2, we performed northern blot analysis. Three isoforms of Tif2 are annotated in the Ensembl database, and a probe consisting of eight common exons was used to detect Tif2 rearrangements. This analysis revealed no altered gene products of Tif2 in the Evi32 tumor 27-186 (Figure 2c). Furthermore, all bands were consistent with previously described Tif2 transcript sizes [12], [13], [14]. All other tumors were also analyzed by northern analysis and no additional transcripts were revealed (data not shown). Together, these analyses indicate that the transcription of Tif2 is not altered with proviral integration at Evi32.
###end p 22
###begin title 23
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Prdm14 is overexpressed in Evi32 tumors
###end title 23
###begin p 24
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Schebesta1">[15]</xref>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
Prdm14 is encoded by eight exons spanning 13.7 kb on mouse chromosome 1. The intron-exon structure of the gene is well conserved with the human homologue PRDM14 on human chromosome 8. The predicted protein of Prdm14 is that of a transcription factor, containing six C2H2 type zinc finger domains and a SET domain. Other proteins containing these domains have been shown to have a role in transcription, such as Blimp1 (Reviewed in [15]).
###end p 24
###begin p 25
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 270 279 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3a</xref>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Q RT-PCR was performed on the Evi32 tumors using the VEGA predicted sequence for Prdm14 as a guide. We found that this transcript was massively upregulated in all tumors containing Evi32 insertions compared to all Evi32 negative AKXD tumors and control tissue examined (Figure 3a). Prdm14 was expressed between 30 and 50 fold more in Evi32 tumors than in control spleen. Moreover, this overexpression was seen in all Evi32 tumors and observed only in those tumors with proviral insertions at Evi32. This shows that overexpression of Prdm14 is limited to AKXD tumors containing Evi32 proviral integrations.
###end p 25
###begin title 26
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Prdm14 is overexpressed in Evi32 tumors.
###end title 26
###begin p 27
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 611 617 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 784 790 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 905 911 905 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1140 1146 1140 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1202 1208 1202 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
3a) Q RT-PCR was performed on cDNA prepared from total RNA samples from AKXD tumors with and without insertions at Evi32 and control tissue obtained from 8 week old C57BL/6J mice. As before, expression levels were normalized to 18S expression then quantified. This analysis revealed that Prdm14 expression was upregulated in all Evi32 tumors. The expression levels of Prdm14 in Evi32 tumors varied between 30 and 50 fold more than in control spleen. 3b) Northern analysis of Prdm14 was performed using total RNA obtained from Evi32 tumors and control tissue obtained from 8 week old C57BL/6J mice. The probe to Prdm14 was nearly the full length coding sequence amplified by PCR. Sizes were estimated using 18S and 26S migration distances. This analysis shows specific upregulation of Prdm14 in all Evi32 tumors. 3c) RT-PCR was performed on Evi32 tumors using a viral 3' LTR specific primer coupled with a Prdm14 second exon primer. cDNA obtained from the 27-001 produced a prominent band consistent with a viral fusion transcript. 3d) The amplicon from 27-001 was sequenced, and viral elements were found to be linked to the second exon of Prdm14 which contains the beginning of the coding sequence of Prdm14. SP = Spleen, LN = Lymph Node, Th = Thymus.
###end p 27
###begin p 28
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 254 263 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3b</xref>
###xml 442 448 442 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Northern analysis was then performed to confirm the overexpression of Prdm14 and determine the size of the Prdm14 transcripts. This analysis showed a high level of expression of Prdm14 specifically in all Evi32 tumors, but not in any control RNA tested (Figure 3b). Two major transcripts were observed in the tumors: one 2.7 kb and one 6.5 kb. The more prominent 2.7 kb transcript is consistent with the VEGA prediction OTTMUSG00000017097 of Prdm14 (). This transcript is also supported by RT-PCR analysis using RNA obtained from tumor tissue (data not shown). The larger transcript could be a pre-mRNA of Prdm14 or the result of altered splicing due to retroviral integration at Evi32. Tumor 27-001 also appeared to have an additional band, which was slightly larger than the 6.5 kb band. However, this additional transcript was not observed in any of the other tumors.
###end p 28
###begin p 29
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Warming1">[16]</xref>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3c</xref>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 466 475 466 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3d</xref>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3c</xref>
###xml 674 680 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 747 753 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 779 785 779 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
To determine whether transcription of Prdm14 was being driven directly from the proviral LTR elements, we performed RT-PCR using viral 3' LTR specific primers [16]. A primer specific to the second exon of Prdm14 (first coding exon) was used as the reverse primer. All Evi32 tumors were analyzed; however, only 27-001 produced a PCR product (Figure 3c). The amplicon was sequenced and showed a fusion between the second exon of Prdm14 and the 3' LTR of the provirus (Figure 3d). This viral fusion transcript could be the additional larger transcript seen in the northern analysis of 27-001 in Figure 3c. The presence of this additional message suggests that transcription of Prdm14 is being driven from the 3' LTR of the provirus and splicing into Prdm14, further suggesting that Prdm14 is being altered specifically by proviral integrations at Evi32.
###end p 29
###begin title 30
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
Normal expression of Prdm14
###end title 30
###begin p 31
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 225 238 225 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g003">Figure 3a, 3b</xref>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 454 463 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g004">Figure 4b</xref>
###xml 537 543 537 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 653 659 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 792 801 792 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g004">Figure 4a</xref>
###xml 868 875 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Niwa1">[17]</xref>
###xml 943 950 943 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 1045 1054 1045 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g004">Figure 4c</xref>
###xml 1090 1097 1090 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 1140 1145 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1207 1214 1207 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 1305 1310 1305 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1358 1363 1358 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1463 1468 1463 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1485 1492 1485 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 1595 1601 1595 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct3/4</italic>
###xml 1616 1621 1616 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1657 1662 1657 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1726 1735 1726 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003823.s002">Figure S2</xref>
Since very little is known about Prdm14, we sought to determine its normal expression pattern. Compared to Evi32 tumors, we found very low levels of expression of Prdm14 in all normal adult tissues as determined by Q RT-PCR (Figure 3a, 3b). We next examined expression of Prdm14 during embryonic development. The highest embryonic levels of expression were found in undifferentiated embryonic stem cells in culture (AB2.2 and Rosa 26 reporter ES cells) (Figure 4b). All other embryonic time points tested showed relatively low levels of Prdm14; however, amongst these, the earlier embryonic stages (starting at E6.5) show higher levels of expression of Prdm14 than do later developmental time points (up to E16.5). The 2.7 kb transcript is present in ES cells, but the 6.5 kb band is absent (Figure 4a). To confirm that the ES cells were in an undifferentiated state, Oct-3/4 was used as a marker of pluripotency [17]. We found high levels of Oct-3/4 expression in the ES cells, with low expression levels in all other embryonic tissues tested (Figure 4c). This analysis also revealed that Oct-3/4 is expressed at relatively high levels in Evi32 tumors, which was striking because we found no expression of Oct-3/4 in control bone marrow and spleen. We examined AKXD tumors without proviral insertions at Evi32 from the AKXD-27 and -18 strains, in which all Evi32 insertions occurred, as well as from the AKXD-9, -10, -13, and -16 strains, which did not have any Evi32 insertions, for Oct-3/4 expression. Although some strains appeared to have lower expression, there was not significantly more Oct3/4 expression in Evi32 tumors compared with those lacking Evi32 integrations (p = 0.53 by the student's t-test) (Supplementary Figure S2).
###end p 31
###begin title 32
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
Prdm14 is expressed most highly in ES cells.
###end title 32
###begin p 33
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 416 422 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
4a) Northern analysis of embryonic tissue compared with the Evi32 tumor 27-186. Gapdh was used as a loading/RNA integrity control. We found expression of the 2.7 kb band in all ES cell samples, but none in any of the other embryonic tissues. The larger 6.5 kb transcript seen in the Evi32 tumor is not found in the ES cells. 4b and c) Quantitative RT-PCR was performed on cDNA obtained from the same tissue from 4a. Prdm14 and Oct-3/4 expression levels were quantified relative to 18S expression levels within each tissue. Expression levels are on a log scale to emphasize lower levels of expression. Results show specific expression of Prdm14 within Oct-3/4 positive ES-cells. All embryonic days are whole embryos unless otherwise indicated. YS = yolk sac.
###end p 33
###begin title 34
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Analysis of Evi32 tumors
###end title 34
###begin p 35
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003823.s003">Table S1</xref>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 904 909 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1110 1115 1110 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 977 982 <span type="species:ncbi:10090">Mouse</span>
Evi32 tumors were originally typed by histopathology and B- and T-cell receptor rearrangements, and were classified as lymphoblastic lymphomas (Supplementary Table S1). Altogether, insertions at Evi32 occurred in 2.0% of the 204 AKXD tumors acquired in this study. However, within AKXD strains 18 and 27, Evi32 integrations occurred in 2.4% (1 of 42 tumors) and 7.3% (3 of 41 tumors) of all tumors, respectively. All three tumors from AKXD strain 27 (27-001, 27-142, and 27-186) were classified as mixed B/T cell by Southern analysis. In total, Evi32 insertions occurred in 13% (3 of 23 total) of the mixed B/T lineage tumors and in 43% (3 of 7 tumors) of the mixed B/T tumors from AKXD-27. The fourth tumor (18-077) was classified as a T-Cell lymphoblastic lymphoma in AKXD strain 18. No Evi32 insertions were identified in 121 tumors from seven other AKXD lines (2, 3, 9, 10, 13, 14, and 16). However, Evi32 retroviral integrations were found in six additional tumors in the Mouse RTCGD. Four of these tumors were classified as B-cell, one was a mixed B-/T-cell, and the last was a myeloid tumor on the BXH2-Runx1+/- background).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF2</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOZ</italic>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Carapeti1">[18]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Liang1">[19]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Deguchi1">[11]</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 785 791 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 864 870 864 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1040 1044 1040 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi3</italic>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Warming1">[16]</xref>
###xml 1138 1144 1138 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1293 1298 1293 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 1336 1342 1336 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 1377 1381 <span type="species:ncbi:10090">mice</span>
In this work, we have demonstrated that Evi32 is a CIS in AKXD mice. All insertions were clustered very tightly at the start of the SET domain-containing gene, Prdm14. Previously, it was thought that insertions at this CIS would affect Tif2, since human TIF2 acts as a fusion oncogene with MOZ[18], [19]. When this fusion oncogene is overexpressed in mice via retroviral transduction, the mice consistently develop acute myeloid leukemia [11], whereas tumors with insertions at Evi32 are lymphoblastic lymphomas. Furthermore, we have found that Tif2 transcripts are not altered in tumors with insertions at Evi32. Instead, each of the tumors with insertions at Evi32 expresses Tif2 at a level that is similar to or lower than normal hematopoietic organs. However, in all Evi32 tumors, Prdm14 is highly overexpressed. Furthermore, in one Evi32 tumor, expression of Prdm14 is driven from the LTR elements of the integrated provirus. Proviral-gene fusions have been observed at other oncogenes, which are activated by the insertion, including Evi3[16]. The chance that a retrovirus would integrate in such a manner as to allow expression of Prdm14 directly from the LTR elements is unlikely without this event contributing to tumor formation. Therefore, we propose that retroviral integration at Evi32 leads to a massive overexpression of Prdm14 contributing to lymphoma in these mice.
###end p 37
###begin p 38
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Hu1">[20]</xref>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Hu1">[20]</xref>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Nishikawa1">[21]</xref>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 584 590 <span type="species:ncbi:10090">murine</span>
There is substantial evidence that PRDM14 is involved in human cancer as well. In a screen for differentially methylated loci in human breast cancer epithelial cells, the second intron of PRDM14 had increased levels of DNA methylation [20]. Higher levels of PRDM14 expression correlated with the increased methylation state in those breast cancer cells [20]. Furthermore, PRDM14 is overexpressed in 57-75% of breast cancers examined and is correlated with genomic amplification at its locus indicating a causative role [21]. Our research indicates that Prdm14 may also be involved in murine leukemia/lymphoma development.
###end p 38
###begin p 39
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM16</italic>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Mochizuki1">[22]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Xinh1">[23]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Sakai1">[24]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-StevensKroef1">[25]</xref>
###xml 210 224 210 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEL1S/sPRDM16,</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Nishikata1">[26]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Xiao1">[27]</xref>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Du1">[28]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Modlich1">[29]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Shing1">[30]</xref>
###xml 567 573 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
Another PR-domain containing gene, PRDM16, has also been implicated in t(1;3)(p36;q21) and t(1;21)(p36;q22) acute myeloid leukemias [22], [23], [24], [25]. In these cases, the short form lacking the PR-domain, MEL1S/sPRDM16, is often overexpressed [26], [27]. Additionally, retroviral integrations in Prdm16 in mouse hematopoietic cells has been associated with myeloid leukemia, as well as the immortalization of progenitor cells [28], [29]. A recent paper implies that the oncogenic potential of PRDM16 lies in sPRDM16, which lacks the PR-domain [30]. However, for Prdm14, we observed high expression of a PR-domain containing transcript in all Evi32 lymphomas. This could indicate that among PRDM family members, the lack of the PR-domain is not always required for transformation.
###end p 39
###begin p 40
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 848 851 848 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 853 856 853 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki1">[5]</xref>
###xml 858 861 858 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Suzuki2">[6]</xref>
###xml 863 866 863 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Yamashita1">[7]</xref>
###xml 899 905 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
Within our screen, all tumors with insertions at Evi32 occurred in mice from only two AKXD lines of nine total strains aged [3]. Furthermore, three of four of the Evi32 tumors were identified from AKXD strain 27. This is probably due to strain specific genetic background differences in strain 27 that predispose mice to Prdm14-induced lymphoid cancer. Therefore, additional genes in AKXD-27 may cooperate with Prdm14. Identifying these cooperating genes may uncover mechanisms by which Evi32 tumorigenesis occurs. This illustrates the importance of using multiple genetic backgrounds in retroviral mutagenesis screens. If AKXD-27 had not been included, Evi32 would not have been identified as a common insertion site in our study. However, it was identified in other screens and in a recent screen in a Bloom Syndrome deficient genetic background [3], [5], [6], [7]. Such information suggests that Prdm14 may predispose to leukemia development only under certain genetic conditions.
###end p 40
###begin p 41
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Yamaji1">[31]</xref>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 136 127 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14<sup>&#8722;/&#8722;</sup></italic>
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 865 871 865 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Boyer1">[32]</xref>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM14</italic>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Greber1">[33]</xref>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 875 880 <span type="species:ncbi:9606">human</span>
###xml 977 982 <span type="species:ncbi:9606">human</span>
Very recently, mice deficient for Prdm14 were generated [31]. While the mice appeared normal; they had impaired fertility. The Prdm14-/- mice failed to develop embryonic germ cells due to a defect in establishment of a pluripotent state and a failure to reset the epigenetic programming in primordial germ cells. These two events are necessary for the formation of embryonic germ cells. Interestingly, expression of the pluripotency marker Oct-3/4 was observed in all AKXD tumors examined here, allowing for the possibility that pluripotency may play a role in tumor susceptibility when Prdm14 is overexpressed. Together, these observations suggest that the function of Prdm14 in tumor development may be promoted in cells with a less differentiated phenotype. It has also been shown that the ES cell pluripotency markers OCT4, SOX2, and NANOG bind the promoter of PRDM14 in human ES cells [32]. si-RNA knockdown of any of these three genes results in a reduction of PRDM14 in human embryonic carcinoma cells [33]. This implies that Prdm14 may be very important in the maintenance of an undifferentiated state since the three major ES cell genes appear to regulate Prdm14 expression in some manner. Unfortunately, the transcriptional targets of Prdm14 remain to be determined; finding these may further elucidate the direct role of Prdm14 in cancer development.
###end p 41
###begin p 42
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Dupuy1">[34]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Collier1">[35]</xref>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 360 366 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 570 575 <span type="species:ncbi:9606">human</span>
This work shows that despite advances in transposable element mutagenesis [34], [35]; retroviral mutagenesis screens still represent a valuable resource for the identification of novel proto-oncogenes involved in leukemogenesis. It also highlights the importance of studying low insertion frequency CISs. Despite Evi32 being identified as a CIS in other work, Prdm14 went unnoticed, likely because of the low numbers of tumors with insertions at this locus. Examination of other genes at CISs that have not been studied could reveal other novel cancer genes relevant to human cancer. Further work on Prdm14 will provide a greater knowledge of the role of SET domain genes in cancer development, as well as a direct link between tumorigenesis and ES cell biology.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
AKXD Tumor Screen and VISA PCR
###end title 44
###begin p 45
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">Mice</span>
###xml 189 194 <span type="species:ncbi:10090">Mouse</span>
All experiments involving mice were carried out under the approval of the Institutional Animal Care and Use Committee at Baylor College of Medicine (BCM). Mice are housed in the Transgenic Mouse Facility at BCM, under the care of the Center for Comparative Medicine, which is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International.
###end p 45
###begin p 46
###xml 307 310 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Weiser1">[3]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Hansen1">[36]</xref>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
Two hundred and four animals from AKXD mouse strains 2, 3, 9, 10, 13, 14, 16, 18, and 27 developed leukemia or lymphoma. Tumors were named first by AKXD strain followed by the animal number, and were classified by histopathology and molecular analysis of B and T-cell rearrangements as previously described [3]. VISA (Viral Insertion Site Amplification) PCR was performed on tumor DNA to identify flanking genomic DNA regions as previously described [3], [36]. BLAST analysis of viral sequence tags (VSTs) was performed to align proviral integrations with the mouse genome. CISs were assembled when multiple VSTs hit a region of less than 25 kb. Tumor information can be found on .
###end p 46
###begin title 47
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
Southern blot analysis of Evi32 tumors
###end title 47
###begin p 48
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 173 182 173 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1b</xref>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003823-g001">Figure 1b</xref>
###xml 343 369 343 369 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAGCCCTGGATCTCTAGCC-3&#8242;</named-content>
###xml 385 411 385 411 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGAAAGGGGCGTTTAATCC-3&#8242;</named-content>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Chattopadhyay1">[37]</xref>
###xml 625 651 625 651 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATGCACACAATGGAGGATT-3&#8242;</named-content>
###xml 666 692 666 692 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCTGACAAGACGGGGTTTG-3&#8242;</named-content>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Justice1">[38]</xref>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
DNA was digested with EcoRV, KpnI, and XbaI. The locations of restriction enzyme sites at the Evi32 locus based on the published C57BL/6J mouse genome sequence are shown in Figure 1b. A 500 bp probe for Evi32 was produced by PCR amplification. Location of the probe is indicated in Figure 1b. Primer sets to generate the probe were: Evi32SPF (5'-AGAGCCCTGGATCTCTAGCC-3') and Evi32SPR (5'-GAGAAAGGGGCGTTTAATCC-3'). The probe to detect retroviral rearrangements was based on pEco, which is directed towards the AKV env gene, and is specific for ecotropic proviruses [37]. The probe was amplified from AKXD tissue with pEcoSPF (5'-CATGCACACAATGGAGGATT-3') and pEcoSPR (5'-GTCTGACAAGACGGGGTTTG-3'). Southern blotting was performed as previously described [38].
###end p 48
###begin title 49
Quantitative RT-PCR (Q RT-PCR)
###end title 49
###begin p 50
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
RNA was produced from snap frozen AKXD tumors and control C57BL/6 tissue using RNA STAT60 (Tel-Test Inc, Friendswood Texas) and extracted by company protocol. cDNA samples were produced from RNA using Multiscribe reverse transcriptase (ABI Systems, Foster City California) with random hexamers. Control tissue was obtained from C57BL/6J mice. Embryonic tissue was obtained after (FVB/N X 129S6/SvEv)F1 female mice were mated with FVB/N male mice and monitored for vaginal plug formation, and then sacrificed at specified embryonic days. Whole embryos were used for RNA preparation. RNA was obtained from ES cell lines AB2.2 and Rosa 26 (R26R), cultured on SNLP 76/7-4 Puro feeder cells. RNA from the feeder cells was also prepared.
###end p 50
###begin p 51
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 213 242 213 242 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGTTCTGAGACgAAGGGTTGGC-3&#8242;</named-content>
###xml 257 288 257 288 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCATCAGACAAAGAAAAACGATAG-3&#8242;</named-content>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slco5a1</italic>
###xml 320 347 320 347 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCCCTTACACAACGGGACCT-3&#8242;</named-content>
###xml 365 394 365 394 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGTCAGATTCCTATGAGGCAT-3&#8242;</named-content>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 432 458 432 458 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGAAGGTCTCTGCCTCATG-3&#8242;</named-content>
###xml 475 502 475 502 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAAAGTGTGGCACATCACCAA-3&#8242;</named-content>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 539 565 539 565 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCAATCAGCTTGGGCTAGA-3&#8242;</named-content>
###xml 580 603 580 603 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGCGCCGGTTACAGAA-3&#8242;</named-content>
###xml 702 728 702 728 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAACCCGTTGAACCCCATT-3&#8242;</named-content>
###xml 742 768 742 768 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCATCCAATCGGTAGTAGCG-3&#8242;</named-content>
###xml 1308 1321 1308 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
Q RT-PCR was performed using the ABI Prism 7000 Sequence Detection System. Primers were designed across exon junctions using Primer Express 3.0 (ABI Systems, Foster City California). Primers to Tif2 were Tif2RTF (5'-AAGTTCTGAGACgAAGGGTTGGC-3') and Tif2RTR (5'-GCCATCAGACAAAGAAAAACGATAG-3'), for Slco5a1 were Slco5a1RTF (5'-ATCCCTTACACAACGGGACCT-3') and Slco5a1RTR (5'-CCTGTCAGATTCCTATGAGGCAT-3'). Primers for Prdm14 were Prdm14RTF (5'-CGGAAGGTCTCTGCCTCATG-3') and Prdm14RTR (5'-CAAAGTGTGGCACATCACCAA-3'). Primers for Oct-3/4 were Oct3/4F (5'-GCCAATCAGCTTGGGCTAGA-3') and Oct3/4R (5'-TGGCGCCGGTTACAGAA-3'). 18S amplification was used to normalize the level of cDNA in each samples using primers 18SRTF (5'-GTAACCCGTTGAACCCCATT-3') and 18SRTR (5'-CCATCCAATCGGTAGTAGCG-3'). All primer sets were optimized by running pairwise combinations of 50 nM, 300 nM, and 900 nM concentrations of forward and reverse primers. SYBR Green 2x master mix (ABI Systems, Foster City California) was used in all reactions. Forty cycles of PCR were used in each Q RT-PCR reaction with a dissociation step to confirm products. All samples were run in triplicate, and error bars represent the standard error of the mean. The relative fold change of gene expression between control and tumor tissue was calculated using the standard 2-DeltaDeltaCt method.
###end p 51
###begin title 52
Northern blot analysis
###end title 52
###begin p 53
###xml 437 438 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 453 455 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 522 528 518 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 631 654 627 650 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGGCCTTACCGCCCTC-3&#8242;</named-content>
###xml 671 700 667 696 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTATGAAGCCTCATGTGGGCAT-3&#8242;</named-content>
###xml 733 739 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm14</italic>
###xml 1014 1018 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 1094 1098 1090 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif2</italic>
###xml 1171 1197 1167 1193 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGTCCAAGGAGGCATGATT-3&#8242;</named-content>
###xml 1212 1238 1208 1234 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTCATCTGGCCTGTCATCT-3&#8242;</named-content>
###xml 763 769 <span type="species:ncbi:10090">murine</span>
Total RNA was prepared from snap frozen tissue using RNA-STAT60 (Tel-Test Inc). 10 ug of RNA was electrophoresed on a 1% agarose gel using Northernmax 10x gel denaturing solution (Ambion, Austin TX) in 1x MOPS. Gel was transferred to Hybond N+ membrane (Amersham Biosciences, Piscataway NJ) using an alkaline transfer buffer (3M NaCl, 0.01M NaOH). Membrane was then analyzed using an UltraHyb (Ambion, Austin TX) solution containing 1x106 cpm/ml [alpha-32P]dATP labeled probe , which was a near full-length coding cDNA of Prdm14 produced by amplification of reverse transcribed cDNA from AKXD tumor 27-001 using primers Prdm14FLF (5'-ATGGCCTTACCGCCCTC-3') and Prdm14FLR (5'-TTTATGAAGCCTCATGTGGGCAT-3'). BLAST analysis of the 1677 bp Prdm14 northern probe against murine cDNA reveals limited homology with other genes. The highest conservation is with ENSMUST00000110739 (zinc finger protein 12) with 100% identity across 24 bp, and the next highest is 87% identity with 40 bp of ENSMUST00000108985 (A2BE20_MOUSE). Tif2 transcripts were analyzed using a probe to eight common exons found in all Tif2 transcript isoforms, which was PCR amplified using primer sets Tif2NPF (5'-CAGTCCAAGGAGGCATGATT-3') and Tif2NPR (5'-GCTCATCTGGCCTGTCATCT-3'). RNA sizes were estimated based on 26S and 18S migration.
###end p 53
###begin title 54
RT-PCR analysis of viral fusions
###end title 54
###begin p 55
###xml 302 326 302 326 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTGGTCTCGCTGATCCT-3&#8242;</named-content>
###xml 363 389 363 389 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCGTGGTACTTCGGGAGTG-3&#8242;</named-content>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003823-Warming1">[16]</xref>
RNA samples were prepared in the same fashion as for Q RT-PCR analysis. cDNA was produced using Superscript III reverse transcriptase (Invitrogen, Carlsbad CA) using oligo(dT) primers. Detection of viral fusion transcripts was performed using primers specific to a unique portion of the 3' LTR of AKV (5'-CGTGGTCTCGCTGATCCT-3'), and to the second exon of Prdm14 (5'-ATCGTGGTACTTCGGGAGTG-3') [16]. After 30 cycles of PCR, the reactions were electrophoresed on a 1% agarose gel. Positive bands were cut out and sequenced.
###end p 55
###begin title 56
Supporting Information
###end title 56
###begin p 57
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pvu</italic>
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 533 541 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003823.s003">Table S1</xref>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
Somatic Ecotropic Viral Integrations in Evi32 tumors. Southern blot analysis was performed on all tumors containing Evi32 integrations using SacI and PvuII digestion. Probe to detect retroviral insertions is directed towards the AKV env gene. Asterisks indicate rearranged bands within the Evi32 positive tumors. Differences in unrearranged band pattern between the AKXD strain 27 and 18 mice indicate the differences in copy number of AKV between the strains. Total numbers of retroviral integrations are tabulated in Supplementary Table S1.
###end p 57
###begin p 58
(5.26 MB TIF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct-3/4</italic>
Oct-3/4 expression in AKXD tumors. Quantitative RT-PCR was performed on AKXD tumor cDNA with or without Evi32 insertions. First four bars from left represent Evi32 positive tumors (27-001, 27-142, 27-186, and 18-077); all others were tested for Evi32 rearrangements by Southern blot analysis and were negative for Evi32 rearrangements. AB2.2 cDNA serves as a positive control for Oct-3/4 expression. Figure shows expression of Oct-3/4 in the majority of AKXD tumors from all lines tested.
###end p 60
###begin p 61
(0.26 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Evi32</italic>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
Summary of tumor data in Evi32 tumors. Table summarizes the types of rearrangements observed in the B- and T-cell receptor in the Evi32 tumors, the pathology of the tumors, the total number of insertions identified using VISA and via Southern blotting, and lastly other common sites identified through sequencing of VSTs. *(27-186 was classified as an enlarged marginal zone, not neoplastic; however, injection of cells obtained from this tumor were able to reconstitute in NOD/SCID mice indicating neoplastic features.)
###end p 63
###begin p 64
(0.03 MB DOC)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
We thank Isabelle Lorenzo of the Baylor College of Medicine Darwin Transgenic Core for donation of the AB2.2 ES cells, and Andy Castillo for the critical reading of this manuscript.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
###xml 26 47 <span type="species:ncbi:11786">murine leukemia virus</span>
Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
###end article-title 68
###begin article-title 69
Retroviral insertional mutagenesis: past, present and future.
###end article-title 69
###begin article-title 70
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.
###end article-title 70
###begin article-title 71
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Susceptibility of AKXD recombinant inbred mouse strains to lymphomas.
###end article-title 71
###begin article-title 72
New genes involved in cancer identified by retroviral tagging.
###end article-title 72
###begin article-title 73
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.
###end article-title 73
###begin article-title 74
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
###end article-title 74
###begin article-title 75
SET domain proteins modulate chromatin domains in eu- and heterochromatin.
###end article-title 75
###begin article-title 76
Unsafe SETs: histone lysine methyltransferases and cancer.
###end article-title 76
###begin article-title 77
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas.
###end article-title 77
###begin article-title 78
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
###end article-title 78
###begin article-title 79
GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.
###end article-title 79
###begin article-title 80
The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.
###end article-title 80
###begin article-title 81
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
###end article-title 81
###begin article-title 82
Transcriptional control of B-cell development.
###end article-title 82
###begin article-title 83
###xml 46 52 <span type="species:ncbi:10090">murine</span>
Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Kruppel-like zinc finger protein.
###end article-title 83
###begin article-title 84
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.
###end article-title 84
###begin article-title 85
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
###end article-title 85
###begin article-title 86
Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
###end article-title 86
###begin article-title 87
Distinct epigenetic changes in the stromal cells of breast cancers.
###end article-title 87
###begin article-title 88
Gene amplification and overexpression of PRDM14 in breast cancers.
###end article-title 88
###begin article-title 89
A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
###end article-title 89
###begin article-title 90
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
###end article-title 90
###begin article-title 91
###xml 43 50 <span type="species:ncbi:9606">patient</span>
Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
###end article-title 91
###begin article-title 92
Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.
###end article-title 92
###begin article-title 93
A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
###end article-title 93
###begin article-title 94
###xml 63 71 <span type="species:ncbi:9606">patients</span>
MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
###end article-title 94
###begin article-title 95
Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.
###end article-title 95
###begin article-title 96
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.
###end article-title 96
###begin article-title 97
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
###end article-title 97
###begin article-title 98
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Critical function of Prdm14 for the establishment of the germ cell lineage in mice.
###end article-title 98
###begin article-title 99
###xml 45 50 <span type="species:ncbi:9606">human</span>
Core transcriptional regulatory circuitry in human embryonic stem cells.
###end article-title 99
###begin article-title 100
###xml 43 48 <span type="species:ncbi:9606">human</span>
Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
###end article-title 100
###begin article-title 101
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system.
###end article-title 101
###begin article-title 102
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.
###end article-title 102
###begin article-title 103
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Genetic profile of insertion mutations in mouse leukemias and lymphomas.
###end article-title 103
###begin article-title 104
###xml 24 45 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Structure of endogenous murine leukemia virus DNA in mouse genomes.
###end article-title 104
###begin article-title 105
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Identification of Evi-3, a novel common site of retroviral integration in mouse AKXD B-cell lymphomas.
###end article-title 105
###begin p 106
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 106
###begin p 107
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Support for the work in this manuscript was provided from NIH grant R01 CA63229 to MJJ. The funding agency had no role in study design, data collection and analysis, decision to publish or prepare the manuscript.
###end p 107

